(-0.12%) 5 462.97 points
(-0.34%) 38 980 points
(0.27%) 17 765 points
(0.33%) $81.10
(-3.48%) $2.66
(-0.92%) $2 309.30
(-0.25%) $28.80
(1.53%) $1 001.50
(0.27%) $0.936
(0.82%) $10.69
(0.36%) $0.791
(-0.27%) $87.25
Live Chart Being Loaded With Signals
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers...
Stats | |
---|---|
本日の出来高 | 0 |
平均出来高 | 1.55M |
時価総額 | 0.00 |
EPS | $-1.100 ( Q2 | 2022-08-05 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-5.24 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.443 (2.21%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-10-14 | Lesser Brian Andrew | Sell | 42 593 | Common Stock |
2022-10-14 | Lesser Brian Andrew | Sell | 37 500 | Stock Option (Right to Buy) |
2022-10-14 | Potts Jeannette | Sell | 37 500 | Stock Option (Right to Buy) |
2022-10-14 | Potts Jeannette | Sell | 43 958 | Common Stock |
2022-10-14 | Fanucci Marsha | Sell | 7 250 | Common Stock |
INSIDER POWER |
---|
-97.46 |
Last 97 transactions |
Buy: 1 770 820 | Sell: 4 300 300 |
ボリューム 相関
Forma Therapeutics 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Forma Therapeutics 相関 - 通貨/商品
Forma Therapeutics 財務諸表
Annual | 2021 |
収益: | $0.00 |
総利益: | $0.00 (0.00 %) |
EPS: | $-4.21 |
FY | 2021 |
収益: | $0.00 |
総利益: | $0.00 (0.00 %) |
EPS: | $-4.21 |
FY | 2020 |
収益: | $0.00 |
総利益: | $0.00 (0.00 %) |
EPS: | $-3.22 |
FY | 2019 |
収益: | $100.56M |
総利益: | $0.00 (0.00 %) |
EPS: | $-3.15 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Forma Therapeutics
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobinopathies; and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company is also developing Olutasidenib, a selective inhibitor for cancers with isocitrate dehydrogenase 1 gene mutations, which is in Phase II trial for the treatment of relapsed/refractory acute myeloid leukemia and Phase I trial to treat glioma; and FT-8225, a liver-targeted fatty-acid synthase inhibitor designed to block de novo lipogenesis in the liver. Forma Therapeutics Holdings, Inc. was founded in 2007 and is headquartered in Watertown, Massachusetts. As of October 14, 2022, Forma Therapeutics Holdings, Inc. operates as a subsidiary of Novo Nordisk A/S.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。